Qube Research & Technologies (QRT)
CYTH icon

Qube Research & Technologies (QRT)’s Cyclo Therapeutics, Inc. Common Stock CYTH Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio CYTH Stock Details CYTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-21
Closed -$27 – 4299
2024
Q2 		$27 Hold
21
– – ﹤0.01% 3558
2024
Q1 		$29 Sell
21
-100
-83% -$165 ﹤0.01% 4249
2023
Q4 		$192 Buy
+121
New +$154 ﹤0.01% 3975

Other funds holding CYTH

ECG
EPIQ Capital Group San Francisco, California $383M AUM 46.87% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
FFVM
Founders Fund VI Management San Francisco, California $45.8K AUM 58.63% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Qube Research & Technologies (QRT)'s CYTH Position: Q3 2024 in Review

Qube Research & Technologies (QRT) sold out of Cyclo Therapeutics, Inc. Common Stock (CYTH) in Q3 2024, closing a stake of 21 shares — an estimated $27 sold.

Qube Research & Technologies (QRT) first reported a position in CYTH in Q4 2023 and held it in 3 quarters. The position peaked at $192 in Q4 2023. 19 funds tracked by Wall St. Rank hold CYTH as of Q3 2024.

  • Qube Research & Technologies (QRT) reported no remaining Cyclo Therapeutics, Inc. Common Stock position as of Q3 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 21 Cyclo Therapeutics, Inc. Common Stock shares in Q3 2024, an estimated $27.
  • Qube Research & Technologies (QRT) first reported a position in Cyclo Therapeutics, Inc. Common Stock in Q4 2023 and held it in 3 quarters.
  • Qube Research & Technologies (QRT)'s Cyclo Therapeutics, Inc. Common Stock position peaked at $192 in Q4 2023.
  • 19 funds tracked by Wall St. Rank held Cyclo Therapeutics, Inc. Common Stock as of Q3 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q3 2024, filed 14 Nov 2024.